# EDGAR Filing Document

**Accession Number:** 0001762304
**File Stem:** 0000902664-23-001806
**Filing Date:** 2023-2
**Character Count:** 13981
**Document Hash:** 3cae3b6da1c83e9413cc8a9e30e01762
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000902664-23-001806.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0000902664-23-001806

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kiniksa Pharmaceuticals, Ltd.
- **CENTRAL INDEX KEY:** 0001730430
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** D0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90491
- **FILM NUMBER:** 23629128

**BUSINESS ADDRESS:**
- **STREET 1:** CLARENDON HOUSE
- **STREET 2:** 2 CHURCH STREET
- **CITY:** HAMILTON
- **STATE:** D0
- **ZIP:** HM11
- **BUSINESS PHONE:** 7814399100

**MAIL ADDRESS:**
- **STREET 1:** CLARENDON HOUSE
- **STREET 2:** 2 CHURCH STREET
- **CITY:** HAMILTON
- **STATE:** D0
- **ZIP:** HM11
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HHLR ADVISORS, LTD.
- **CENTRAL INDEX KEY:** 0001762304
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** OFFICE #122, WINDWARD 3 BUILDING
- **STREET 2:** REGATTA OFFICE PARK, WEST BAY ROAD
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-9006
- **BUSINESS PHONE:** (345) 749-8643

**MAIL ADDRESS:**
- **STREET 1:** OFFICE #122, WINDWARD 3 BUILDING
- **STREET 2:** REGATTA OFFICE PARK, WEST BAY ROAD
- **CITY:** GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-9006

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HILLHOUSE CAPITAL ADVISORS, LTD.
- **DATE OF NAME CHANGE:** 20190510

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hillhouse Capital Advisors, Ltd.
- **DATE OF NAME CHANGE:** 20181218

---

| | |
|:---|:---|
| &nbsp;&nbsp;SECURITIES AND EXCHANGE COMMISSION | &nbsp;&nbsp;SECURITIES AND EXCHANGE COMMISSION |
| &nbsp;&nbsp;Washington, D.C. 20549 | &nbsp;&nbsp;Washington, D.C. 20549 |
| &nbsp;&nbsp;SCHEDULE 13G/A | &nbsp;&nbsp;SCHEDULE 13G/A |
| &nbsp;&nbsp;Under the Securities Exchange Act of 1934 | &nbsp;&nbsp;Under the Securities Exchange Act of 1934 |
| &nbsp;&nbsp;(Amendment No. 3)\* | &nbsp;&nbsp;(Amendment No. 3)\* |
| &nbsp;&nbsp; Kiniksa Pharmaceuticals, Ltd. | &nbsp;&nbsp; Kiniksa Pharmaceuticals, Ltd. |
| &nbsp;&nbsp;(Name of Issuer) | &nbsp;&nbsp;(Name of Issuer) |
| &nbsp;&nbsp; Class A Common Shares, par value $0.000273235 per share | &nbsp;&nbsp; Class A Common Shares, par value $0.000273235 per share |
| &nbsp;&nbsp;(Title of Class of Securities) | &nbsp;&nbsp;(Title of Class of Securities) |
| &nbsp;&nbsp; G5269C101 | &nbsp;&nbsp; G5269C101 |
| &nbsp;&nbsp;(CUSIP Number) | &nbsp;&nbsp;(CUSIP Number) |
| &nbsp;&nbsp; December 31, 2022 | &nbsp;&nbsp; December 31, 2022 |
| &nbsp;&nbsp;(Date of Event Which Requires Filing of This Statement) | &nbsp;&nbsp;(Date of Event Which Requires Filing of This Statement) |
| &nbsp;&nbsp;Check the appropriate box to designate the rule pursuant to which this Schedule is filed: | &nbsp;&nbsp;Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
| &nbsp;&nbsp;🗷 | &nbsp;&nbsp;Rule 13d-1(b) |
| &nbsp;&nbsp;◻ | &nbsp;&nbsp;Rule 13d-1(c) |
| &nbsp;&nbsp;◻ | &nbsp;&nbsp;Rule 13d-1(d) |
| &nbsp;&nbsp;(Page 1 of 5 Pages) | &nbsp;&nbsp;(Page 1 of 5 Pages) |

---

______________________________

\*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("<u>Act</u>") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

---

| | | |
|:---|:---|:---|
| **CUSIP No. G5269C101** | **13G/A** | **Page 2 of 5 Pages** |

---

---

| | | | |
|:---|:---|:---|:---|
| **1** | &nbsp;&nbsp; NAME OF REPORTING PERSON<br> HHLR Advisors, Ltd. | &nbsp;&nbsp; NAME OF REPORTING PERSON<br> HHLR Advisors, Ltd. | &nbsp;&nbsp; NAME OF REPORTING PERSON<br> HHLR Advisors, Ltd. |
| **2** | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | &nbsp;&nbsp;CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP | &nbsp;&nbsp; (a) ◻<br> (b) ◻ |
| **3** | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY | &nbsp;&nbsp;SEC USE ONLY |
| **4** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CITIZENSHIP OR PLACE OF ORGANIZATION<br> Cayman Islands | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CITIZENSHIP OR PLACE OF ORGANIZATION<br> Cayman Islands | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; CITIZENSHIP OR PLACE OF ORGANIZATION<br> Cayman Islands |
| &nbsp;&nbsp;NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH: | **5** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SOLE VOTING POWER<br> 2,623,924 Class A Common Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SOLE VOTING POWER<br> 2,623,924 Class A Common Shares |
| &nbsp;&nbsp;NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH: | **6** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SHARED VOTING POWER<br> -0- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SHARED VOTING POWER<br> -0- |
| &nbsp;&nbsp;NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH: | **7** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SOLE DISPOSITIVE POWER<br> 2,623,924 Class A Common Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SOLE DISPOSITIVE POWER<br> 2,623,924 Class A Common Shares |
| &nbsp;&nbsp;NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON WITH: | **8** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SHARED DISPOSITIVE POWER<br> -0- | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SHARED DISPOSITIVE POWER<br> -0- |
| **9** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> 2,623,924 Class A Common Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> 2,623,924 Class A Common Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br> 2,623,924 Class A Common Shares |
| **10** | &nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | &nbsp;&nbsp;CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES | &nbsp;&nbsp;◻ |
| **11** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br> 7.6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br> 7.6% | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br> 7.6% |
| **12** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TYPE OF REPORTING PERSON<br> IA | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TYPE OF REPORTING PERSON<br> IA | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TYPE OF REPORTING PERSON<br> IA |

---

---

| | | |
|:---|:---|:---|
| **CUSIP No. G5269C101** | **13G/A** | **Page 3 of 5 Pages** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;**Item 1(a).** | **NAME OF ISSUER** |
|  | The name of the issuer is Kiniksa Pharmaceuticals, Ltd. (the "<u>Company</u>"). |

---

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;**Item 1(b).** | **ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES** | **ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES** |
|  | The Company's principal executive office is located at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda. | The Company's principal executive office is located at Clarendon House, 2 Church Street, Hamilton HM11, Bermuda. |
| &nbsp;&nbsp;**Item 2 (a).** | **NAME OF PERSON FILING** | **NAME OF PERSON FILING** |
|  | This statement is filed by HHLR Advisors, Ltd., an exempted Cayman Islands company ("<u>HHLR</u>" or the "<u>Reporting Person</u>"), with respect to the Class A Common Shares (as defined in Item 2(d) below) held by HHLR Fund, L.P. ("<u>HHLR Fund</u>"). HHLR acts as the sole investment manager of HHLR Fund. HHLR is hereby deemed to be the sole beneficial owner of, and to control the voting and investment power of, the Class A Common Shares held by HHLR Fund. | This statement is filed by HHLR Advisors, Ltd., an exempted Cayman Islands company ("<u>HHLR</u>" or the "<u>Reporting Person</u>"), with respect to the Class A Common Shares (as defined in Item 2(d) below) held by HHLR Fund, L.P. ("<u>HHLR Fund</u>"). HHLR acts as the sole investment manager of HHLR Fund. HHLR is hereby deemed to be the sole beneficial owner of, and to control the voting and investment power of, the Class A Common Shares held by HHLR Fund. |
| &nbsp;&nbsp;**Item 2(b).** | **ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE** | **ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE** |
|  | The address of the business office of the Reporting Person is Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands, KY1-9006. | The address of the business office of the Reporting Person is Office #122, Windward 3 Building, Regatta Office Park, West Bay Road, Grand Cayman, Cayman Islands, KY1-9006. |
| **Item 2(c).** | **CITIZENSHIP** | **CITIZENSHIP** |
|  | Cayman Islands | Cayman Islands |
| &nbsp;&nbsp;**Item 2(d).** | **TITLE OF CLASS OF SECURITIES** | **TITLE OF CLASS OF SECURITIES** |
|  | Class A Common Shares, par value $0.000273235 per share (the "<u>Class A Common Shares</u>"). | Class A Common Shares, par value $0.000273235 per share (the "<u>Class A Common Shares</u>"). |
| &nbsp;&nbsp;**Item 2(e).** | **CUSIP NUMBER** | **CUSIP NUMBER** |
|  | G5269C101 | G5269C101 |
| &nbsp;&nbsp;**Item 3.** | **IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:** | **IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:** |
| &nbsp;&nbsp; (a) | &nbsp;&nbsp;◻ | &nbsp;&nbsp;Broker or dealer registered under Section 15 of the Act; |
| &nbsp;&nbsp; (b) | &nbsp;&nbsp;◻ | &nbsp;&nbsp;Bank as defined in Section 3(a)(6) of the Act; |
| &nbsp;&nbsp; (c) | &nbsp;&nbsp;◻ | &nbsp;&nbsp;Insurance company as defined in Section 3(a)(19) of the Act; |
| &nbsp;&nbsp; (d) | &nbsp;&nbsp;◻ | &nbsp;&nbsp;Investment company registered under Section 8 of the Investment Company Act of 1940; |
| &nbsp;&nbsp; (e) | &nbsp;&nbsp;🗷 | &nbsp;&nbsp;An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
| &nbsp;&nbsp; (f) | &nbsp;&nbsp;◻ | &nbsp;&nbsp; An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);<br>|
| &nbsp;&nbsp; (g) | &nbsp;&nbsp;◻ | &nbsp;&nbsp; A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);<br>|

---

---

| | | |
|:---|:---|:---|
| **CUSIP No. G5269C101** | **13G/A** | **Page 4 of 5 Pages** |

---

(h) ◻ A savings association as defined in Section 3(b) of the
 Federal Deposit Insurance Act;

(i) ◻ A church plan that is excluded from the definition of
 an investment company under Section 3(c)(14) of the Investment Company Act;

(j) ◻ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);

(k) ◻ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

---

| | |
|:---|:---|
|  | If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please<br> specify the type of institution: _______________________________ |
| &nbsp;&nbsp;**Item 4.** | **OWNERSHIP** |
|  | The percentage set forth in this Schedule 13G/A is calculated based upon an aggregate of 34,531,084 Class A Common Shares outstanding as of October 31, 2022, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 filed with the Securities and Exchange Commission on November 3, 2022. |
|  | The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for the Reporting Person and is incorporated herein by reference. |
| &nbsp;&nbsp;**Item 5.** | **OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS** |
|  | Not applicable. |
| &nbsp;&nbsp;**Item 6.** | **OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON** |
|  | See Item 2. |
| &nbsp;&nbsp;**Item 7.** | **IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON** |
|  | Not applicable. |
| &nbsp;&nbsp;**Item 8.** | **IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP** |
|  | Not applicable. |
| &nbsp;&nbsp;**Item 9.** | **NOTICE OF DISSOLUTION OF GROUP** |
|  | Not applicable. |
| &nbsp;&nbsp;**Item 10.** | **CERTIFICATION** |
|  | The Reporting Person hereby makes the following certification: |
|  | By signing below the Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |

---

---

| | | |
|:---|:---|:---|
| **CUSIP No. G5269C101** | **13G/A** | **Page 5 of 5 Pages** |

---

**SIGNATURES**

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

DATE: February 14, 2023

---

| |
|:---|
| **HHLR Advisors, LTD.** |
| /s/ Audrey Woon |
| Name: Audrey Woon |
| Title: Chief Compliance Officer |

---